Skip to main content

NeuroX Innovations

Humanizing Prosthetics

Revolutionizing Pain Management for Amputees

NeuroX is transforming chronic pain relief with cutting-edge wearable technology. Our breakthrough device provides non-pharmaceutical pain management, giving amputees a new path to relief and improved quality of life.

How It Works

Harnessing advanced neuromodulation technology, our wearable device targets the nervous system to reduce pain at its source—without drugs, invasive procedures, or side effects.

  • Innovative Technology – Rooted in clinical expertise and powered by cutting-edge neuromodulation technology.
  • Drug-Free Relief – Reducing dependence on opioids and other pharmaceuticals.
  • Seamless Integration – Comfortable, easy-to-use technology that fits into daily life.

Our Team

The NeuroX team brings over 180 years of combined executive experience across capital formation, SaaS operations, software engineering, corporate strategy, M&A, sales, global market development, and risk management. Comprised of seasoned industry leaders, we are dedicated to advancing innovative solutions that transform patient care.

CEO | Board Member

Robert Kline

Robert is a seasoned entrepreneur with over 25 years in healthcare and life sciences, known for building companies from concept to commercialization and exit. He is an EY Entrepreneur of The Year™ and currently serves as CEO of NeuroX Innovations, In addition to NeuroX, Robert chairs Fifth Eye Medical and holds Board positions with several other healthcare companies. His past ventures include Medivance (acquired for $260M) and ViroCyt (acquired for 10X revenue). He also recently led Bolder Surgical which was ac-quired for $160M (16X Revenue). Robert holds an MBA, an MS in Microbiology, and a BA in Chemistry.
Co-Founder | President | Board Member

Jordan Doles

Jordan is the founder and inventor behind NeuroX’s innovative medical devices aimed at alleviating Phantom Limb Syndrome (PLS) and Residual Limb Pain (RLP) in amputees. With a degree in Cell and Molecular Neuroscience, his research into PLS helped shape NeuroX’s product lineup, including NXI Sense, NXI Pulse, and MySkeletronX. As President, Jordan focuses on driving strategic growth and overseeing operations. He is the named inventor on over 15 NeuroX patent filings, and has played a critical role in securing several million dollars in funding for the company.
Co-Founder | Board Chair

Scott Fardulis

Scott brings over 30 years of entre-preneurial experience in strategic planning, business development, consulting, and international market expansion across 25+ countries. As a founder and chairman of NeuroX Innovations, he has been instrumental in shaping the company’s direction, attracting highvalue investors, and guiding both short- and long-term strategies. Scott plays a key role in maintaining strong investor communications, and his leadership has helped recruit key talent, and ensure operational efficiency. Beyond NeuroX, Scott is a successful entrepreneur, sales, and marketing leader, with a focus on mentoring, personal development, and relationship building.
Co-Founder | Board Director

Gary McAdam

Gary brings over 40 years of experience in developing early-stage growth companies. At NeuroX, he applies his expertise in strategic planning, corporate development, governance, and crafting a clear corporate vision. He also plays a key role in developing NeuroX’s intellectual property. Gary excels in attracting and negotiating key talent, capital structuring, and investor communications to maximize shareholder value. With refined insights from numerous successful partnerships, mergers, acquisitions, and IPOs, Gary’s track record includes helping companies that have matured to raise billions in capital or achieve acquisition.

"*" indicates required fields

Name*
Please let us know what's on your mind. Have a question for us? Ask away.
This field is for validation purposes and should be left unchanged.